abrdn Healthcare Investors (NYSE:HQH – Get Free Report) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 49,111 shares, a decrease of 20.4% from the March 31st total of 61,693 shares. Based on an average daily trading volume, of 158,021 shares, the short-interest ratio is currently 0.3 days. Approximately 0.1% of the shares of the stock are short sold.
Institutional Investors Weigh In On abrdn Healthcare Investors
Hedge funds have recently bought and sold shares of the business. Eastern Bank bought a new position in abrdn Healthcare Investors during the third quarter valued at $30,000. Guerra Advisors Inc purchased a new stake in shares of abrdn Healthcare Investors during the 3rd quarter valued at about $39,000. Geneos Wealth Management Inc. raised its position in shares of abrdn Healthcare Investors by 9,232.3% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after buying an additional 2,862 shares in the last quarter. Flagship Harbor Advisors LLC bought a new position in shares of abrdn Healthcare Investors in the 4th quarter valued at about $48,000. Finally, Advisory Services Network LLC bought a new position in shares of abrdn Healthcare Investors in the 3rd quarter valued at about $97,000. Hedge funds and other institutional investors own 32.60% of the company’s stock.
abrdn Healthcare Investors Stock Performance
NYSE HQH traded down $0.13 during trading on Friday, hitting $19.72. 78,024 shares of the stock traded hands, compared to its average volume of 130,161. abrdn Healthcare Investors has a 12-month low of $15.09 and a 12-month high of $20.46. The firm has a 50-day simple moving average of $18.77 and a 200-day simple moving average of $18.98.
abrdn Healthcare Investors Increases Dividend
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Read More
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
